Related Experiment Video
Updated: Apr 21, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
[The genome and cancer treatment]
Finn Cilius Nielsen1, Ulrik Lassen
1Klinisk Biokemi, Righospitalet, Blegdamsvej 9, 2100 København Ø. fcn@rh.dk.
Abstract:
Basic research has uncovered the molecular pathogenesis of both sporadic and hereditary cancer and this has paved the way for the use of genome-wide technologies to depict the molecular drivers of individual tumours and for development of personalized and targeted treatment. This review describes the recent application of next generation sequencing and microarrays in the classification of cancers and the prospects of personalized medicine in oncology.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes